These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7511671)

  • 1. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
    Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
    J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
    Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
    J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
    Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
    J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
    Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
    J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
    Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
    J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
    Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H
    Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor.
    Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N
    J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.